MCM
DVAX

Moore Capital Management’s Dynavax Technologies DVAX Stock Holding History

Moore Capital Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-155,000
Closed -$3.75M – 265
2015
Q4 		$3.75M Buy
155,000
+80,000
+107% +$2M 0.12% 154
2015
Q3 		$1.84M Buy
+75,000
New +$2.12M 0.09% 209

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Amici Capital New York $257M AUM 4.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GA
Glenhill Advisors New York $6.94M AUM 24.62% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Moore Capital Management's DVAX Position: Q1 2016 in Review

Moore Capital Management sold out of Dynavax Technologies (DVAX) in Q1 2016, closing a stake of 155,000 shares — an estimated $3.75M sold.

Moore Capital Management first reported a position in DVAX in Q3 2015 and held it in 2 quarters. The position peaked at $3.75M in Q4 2015. 130 funds tracked by Wall St. Rank hold DVAX as of Q1 2016.

  • Moore Capital Management reported no remaining Dynavax Technologies position as of Q1 2016 after selling out during the quarter.
  • Moore Capital Management sold 155,000 Dynavax Technologies shares in Q1 2016, an estimated $3.75M.
  • Moore Capital Management first reported a position in Dynavax Technologies in Q3 2015 and held it in 2 quarters.
  • Moore Capital Management's Dynavax Technologies position peaked at $3.75M in Q4 2015.
  • 130 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2016.

Based on Moore Capital Management's 13F filing for Q1 2016, filed 16 May 2016.